Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Protocols in Pharmacology|September 3, 2014
Overview of mouse models of autism spectrum disordersAlexandra L Bey, Yong-Hui Jiang
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|December 28, 2012
Synaptic plasticity in mouse models of autism spectrum disordersLeeyup Chung, Alexandra L Bey, Yong-Hui Jiang
Brain and Behavior|October 15, 2018
Environmental enrichment has minimal effects on behavior in the Shank3 complete knockout model of autism spectrum disorderSamuel W Hulbert, Alexandra L Bey, Yong-Hui Jiang
Plos Genetics|August 19, 2007
The role of AtMUS81 in interference-insensitive crossovers in A. thalianaLuke E Berchowitz, Kirk E Francis, Alexandra L Bey, et al.
Molecular Autism|July 30, 2014
Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant miceXiaoming Wang, Qiong Xu, Alexandra L Bey, et al.
Developmental Neurobiology|March 29, 2013
Therapeutic approaches for shankopathiesXiaoming Wang, Alexandra L Bey, Leeyup Chung, et al.
Neurobiology of Disease|November 4, 2017
Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome modelLeeyup Chung, Alexandra L Bey, Aaron J Towers, et al.
The American Journal of Pathology|September 1, 2009
Epithelial integrity is maintained by a matriptase-dependent proteolytic pathwayKarin List, Peter Kosa, Roman Szabo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Pollen tetrad-based visual assay for meiotic recombination in ArabidopsisKirk E Francis, Sandy Y Lam, Benjamin D Harrison, et al.
Pediatrics|February 5, 2020
Subacute Neuropsychiatric Syndrome in Girls With SHANK3 Mutations Responds to ImmunomodulationAlexandra L Bey, Mark P Gorman, William Gallentine, et al.
Pageof 3